The FDA has approved Avlayah (tividenofusp alfa-eknm) to treat the neurological manifestations of Hunter syndrome in pediatric patients. In a phase 1/2 clinical trial, the treatment led to a 91% ...
Shara Bialo, MD, explains why immunologic screening for islet autoantibodies is essential to identifying type 1 diabetes in its presymptomatic stages. In this interview with Contemporary Pediatrics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results